ArticleThoracic cancer2023
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors.
Registry-linked trialOpen access · goldAbstract readConsensus Statement
In one paragraph
Article in Thoracic cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07343453 (A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT07343453 phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation
A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.
- The effectiveness of adjuvant radiotherapy after thymoma resection: a systematic review and meta-analysis.World journal of surgical oncology · 2025Pooled it
- Multi-modal prediction model for thymic epithelial tumors: Enhancing surgical decisions and recurrence risk assessment from CT datasets.European journal of radiology open · 2026Article
- Myasthenia Gravis and Thymoma.Muscle & nerve · 2026Review
- Immunotherapy Safety in Thymic Epithelial Tumors: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System.JMIR cancer · 2026Article
- Fe metal-organic framework-derived heterojunction for metabolic diagnosis of thymic epithelial tumor.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- The role of adjuvant chemotherapy in patients with thymoma and thymic carcinoma following surgery: a systematic literature review and meta-analysis.Journal of thoracic disease · 2025Article
- A case report of primary mucinous adenocarcinoma of the thymus and review of the literature.Journal of surgical case reports · 2025Article
- Clinical outcomes of subxiphoid uniportal video-assisted thoracoscopic thymectomy using a double sternum retractor versus conventional approaches.Journal of thoracic disease · 2025Article
- Nomogram for predicting the prognosis of metastatic thymic epithelial tumors.Journal of thoracic disease · 2025Article
- Radiomics in thymic epithelial tumors: a scoping review of current status and advances.BMC cancer · 2025Article
- Surveillance of thymic epithelial tumors (TETs)-a narrative review.Mediastinum (Hong Kong, China) · 2025Review
- Recurrent Thymic Carcinoma Treated With Median Sternotomy, Innominate Vein Replacement for Superior Vena Cava, and Iodide Implantation: A Case Report and Review of the Literature.Cancer reports (Hoboken, N.J.) · 2025Review
- Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess.Frontiers in pharmacology · 2025Article
- Identification of the immune-associated enhancer RNA SATB1-AS1 as a novel biomarker for thymic cancer prognosis.PloS one · 2025Article
- Case Report: Robust and durable response to the combination of tislelizumab and chemotherapy in advanced thymic epithelial tumors: a case series.Frontiers in immunology · 2025Article
- Machine learning-based radiomics analysis in enhancing CT for predicting pathological subtypes and WHO staging of thymic epithelial tumors: a multicenter study.American journal of cancer research · 2025Article
- Long-term outcomes of robot versus video-assisted thymectomy for thymic epithelial tumors: a propensity matched analysis.BMC surgery · 2024Article
- Clinical features and prognostic factors in thymoma and thymic carcinoma.Indian journal of thoracic and cardiovascular surgery · 2024Article
- Postoperative radiotherapy after extirpative surgery may not improve survival in patients with Masaoka-Koga stage IIB thymoma: a propensity-matched study based on the SEER database.Journal of thoracic disease · 2024Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
108 authors at 20 institutions in 2 countries.
Chunwei XuInstitute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, People's Republic of China.ORCID 0000-0002-9021-6731
Yongchang ZhangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.ORCID 0000-0002-6829-7176
Wenxian WangDepartment of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China.ORCID 0000-0002-3047-4149
Qian WangDepartment of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, People's Republic of China.
Ziming LiDepartment of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Zhengbo SongDepartment of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China.ORCID 0000-0002-4817-7775
Jiandong WangDepartment of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Jinpu YuDepartment of Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Jingjing LiuDepartment of Thoracic Cancer, Jilin Cancer Hospital, Jilin, People's Republic of China.
Shirong ZhangTranslational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.ORCID 0000-0001-9334-1637
Xiuyu CaiDepartment of VIP Inpatient, Sun Yet-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Ming WuDepartment of Thoracic Surgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, People's Republic of China.ORCID 0000-0002-1009-5387
Ping ZhanDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Hongbing LiuDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.ORCID 0000-0003-1404-0647
Tangfeng LvDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Liyun MiaoDepartment of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.ORCID 0000-0001-9586-3244
Lingfeng MinDepartment of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, People's Republic of China.
Jiancheng LiDepartment of Radiation Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Baogang LiuDepartment of Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
Jingping YuanDepartment of Pathology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Zhansheng JiangDerpartment of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.ORCID 0000-0002-5707-5148
Gen LinDepartment of Medical Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, People's Republic of China.ORCID 0000-0001-9411-5519
Xiaohui ChenDepartment of Thoracic Surgery, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Xingxiang PuDepartment of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Chuangzhou RaoDepartment of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China.
Dongqing LvDepartment of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, People's Republic of China.
Zongyang YuDepartment of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, People's Republic of China.
Xiaoyan LiDepartment of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
Chuanhao TangDepartment of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China.
Chengzhi ZhouState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, People's Republic of China.ORCID 0000-0003-0029-6879
Junping ZhangDepartment of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Hui GuoDepartment of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Qian ChuDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Rui MengCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Xuewen LiuDepartment of Oncology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Jingxun WuDepartment of Medical Oncology, the First Affiliated Hospital of Medicine, Xiamen University, Xiamen, People's Republic of China.
Xiao HuZhejiang Key Laboratory of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China.
Min FangZhejiang Key Laboratory of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China.
Jin ZhouDepartment of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu, People's Republic of China.
Zhengfei ZhuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.ORCID 0000-0001-7537-3619
Xiaofeng ChenDepartment of Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, People's Republic of China.
Weiwei PanDepartment of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, People's Republic of China.
Fei PangDepartment of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Yuxiang ZhouDepartment of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Qijie JianDepartment of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Kai WangDepartment of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Liping WangDepartment of Oncology, Baotou Cancer Hospital, Baotou, People's Republic of China.
Youcai ZhuDepartment of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.
Guocai YangDepartment of Thoracic Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhejiang, People's Republic of China.
Xinqing LinState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, People's Republic of China.ORCID 0000-0001-9436-2229
Jing CaiDepartment of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.ORCID 0000-0002-6792-4959
Lijun LiangDepartment of Thoracic Surgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, People's Republic of China.
Huijing FengDepartment of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Lin WangDepartment of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Yingying DuDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.ORCID 0000-0002-5149-4632
Wang YaoDepartment of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Xuefei ShiDepartment of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, People's Republic of China.
Xiaomin NiuDepartment of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Dongmei YuanDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Yanwen YaoDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Jianhui HuangDepartment of Oncology, Lishui Municipal Central Hospital, Lishui, People's Republic of China.
Yinbin ZhangDepartment of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Pingli SunDepartment of Pathology, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Hong WangSenior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, People's Republic of China.
Mingxiang YeDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Dong WangDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Zhaofeng WangDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Yue HaoDepartment of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China.ORCID 0000-0002-4725-6084
Zhen WangDepartment of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Bing WanDepartment of Respiratory Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Donglai LvDepartment of Clinical Oncology, The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, People's Republic of China.ORCID 0000-0003-4128-6853
Genhua YuDepartment of Radiation Oncology, Zhebei Mingzhou Hospital, Huzhou, People's Republic of China.
Anna LiGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Jin KangGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Jiatao ZhangGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Chao ZhangGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Huafei ChenDepartment of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.
Lin ShiDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Leiguang YeDepartment of Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
Gaoming WangDepartment of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, People's Republic of China.
Yina WangDepartment of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Feng GaoDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Wei ZhouInstitute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, People's Republic of China.
Chunxiu HuDepartment of Cancer Radiotherapy and Chemotherapy, Zhejiang Queue Hospital, Quzhou, People's Republic of China.
Jianguo WeiDepartment of Pahtology, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, People's Republic of China.
Bihui LiDepartment of Oncology, The Second Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Zhongwu LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Yuan LiDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Zhefeng LiuSenior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, People's Republic of China.
Nong YangDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Lin WuDepartment of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Qiming WangDepartment of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Wenbin HuangDepartment of Pathology, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, People's Republic of China.
Zhuan HongDepartment of Medical Oncology, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, People's Republic of China.
Guansong WangInstitute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Meiyu FangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Yong FangDepartment of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.
Xixu ZhuDepartment of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Kaiqi DuDepartment of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.
Jiansong JiDepartment of Radiology, Lishui Municipal Central Hospital, Lishui, People's Republic of China.
Yi ShenDepartment of Thoracic Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.ORCID 0000-0002-2144-882X
Yiping ZhangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Shenglin MaDepartment of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Yong SongDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.ORCID 0000-0003-4979-4131
Yuanzhi LuDepartment of Clinical Pathology, The First Affiliated Hospital Of Jinan University, Guangzhou, People's Republic of China.ORCID 0000-0003-2946-643X
Anwen LiuDepartment of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Wenfeng FangDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Wenzhao ZhongGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.ORCID 0000-0002-8917-8635
Nanjing General Hospital of Nanjing Military Command · CNCentral South University · CNGuangdong Academy of Medical Sciences · CNChinese Academy of Sciences · CNFujian Medical University · CNJiaxing University · CNShanghai Medical Information Center · CNSun Yat-sen University · CNZhejiang Cancer Hospital · CNArmy Medical University · CNBaogang Group (China) · CNChinese PLA General Hospital · CNFirst Affiliated Hospital of Guangzhou Medical University · CNFudan University Shanghai Cancer Center · CNHarbin Medical University · CNLishui Central Hospital · CNNanchang University · CNNanjing University of Chinese Medicine · CNNantong University · CNPeking University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete surgical resection is recommended. Radiotherapy or chemotherapy may be used as postoperative adjuvant treatment. Treatment for advanced, unresectable TETs consist mainly of radiotherapy and chemotherapy, but there is a lack of standard first- and second-line treatment regimens. Recently, targeted therapies and immune checkpoint inhibitors have shown promising outcomes in TETs. Based on the currently available clinical evidences and the opinions of the national experts, the Thymic Oncology Group of Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) established this Chinese expert consensus on the clinical diagnosis and treatment of TETs, covering the epidemiology, diagnosis, treatment, prognosis and follow-up of TETs.
Indexed as
Neoplasms, Glandular and EpithelialThymus NeoplasmsChinaHumansdiagnosisthymic carcinomathymic epithelial tumorthymomatreatment
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT07343453ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.